Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lower limb embolectomy in old age.

H Allermand, J Westergaard-Nielsen, O S Nielsen

    The Journal of Cardiovascular Surgery
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Embolectomy is a viable treatment for acute embolic lower limb ischemia in elderly patients, with a high success rate in limb salvage and minimal impact on mortality, even if amputation is later required.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Functional outcome in sarcomas treated with limb-salvage surgery or amputation.

    Sarcoma·2008
    Same author

    Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group.

    Sarcoma·2008
    Same author

    Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.

    European journal of cancer (Oxford, England : 1990)·2007
    Same author

    Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.

    European journal of cancer (Oxford, England : 1990)·2006
    Same author

    Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
    Same journal

    Development of a new dedicated bridging stent for FEVAR: initial ideas, design and testing, on-label approval, and initial experience.

    The Journal of cardiovascular surgery·2026
    Same journal

    Pelvic venous disease and lymphatic dysfunction: evaluating the evidence for a proposed continuum.

    The Journal of cardiovascular surgery·2026
    Same journal

    Incidence of post-dissection aneurysmal formation and need for secondary intervention after surgery for acute type A aortic dissections: a systematic review and meta-analysis of observational studies.

    The Journal of cardiovascular surgery·2026
    Same journal

    The expertise effect: how advancing skills in frozen elephant trunk have broadened surgical indication for acute dissection.

    The Journal of cardiovascular surgery·2026
    Same journal

    Outcomes of pulmonary embolism response teams: a systematic review.

    The Journal of cardiovascular surgery·2026
    Same journal

    Use of large bore devices in the treatment of pulmonary embolism.

    The Journal of cardiovascular surgery·2026
    See all related articles

    Area of Science:

    • Vascular Surgery
    • Geriatric Medicine
    • Cardiovascular Medicine

    Background:

    • Acute embolic lower limb ischemia poses significant risks in elderly patients.
    • High mortality rates are associated with surgical interventions in this demographic.

    Purpose of the Study:

    • To evaluate the outcomes of embolectomy in patients aged 80 and above with acute embolic lower limb ischemia.
    • To assess the impact of embolectomy on mortality, limb salvage, and functional status.

    Main Methods:

    • Retrospective analysis of 56 patients aged 80+ undergoing embolectomy for acute lower limb ischemia.
    • Data collection on mortality, need for amputation, and functional outcomes.

    Main Results:

    • Overall mortality rate was 32%.

    Related Experiment Videos

  • Patients with simultaneous myocardial infarction had a 100% mortality rate.
  • 29 out of 38 survivors avoided amputation, maintaining their social and functional status.

    • Conclusions:

    • Embolectomy is a recommended treatment for acute embolic lower limb ischemia in octogenarians.
    • Unsuccessful embolectomy does not increase mortality risk if subsequent amputation is necessary.
    • The procedure offers a good chance of limb salvage and functional preservation in elderly patients.